Intravenous immunoglobulin improves live birth rates in patients with unexplained recurrent pregnancy loss
Authors:
Open Access
- 26 August 2024
- journal article
- research article
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 166, 104322
Abstract
No abstract availableKeywords
Funding Information
- Lanzhou University Second Hospital
- Lanzhou University
This publication has 41 references indexed in Scilit:
- Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trialeClinicalMedicine, 2022
- NK cell frequency and cytotoxicity in correlation to pregnancy outcome and response to IVIG therapy among women with recurrent pregnancy lossJournal of Cellular Physiology, 2018
- Intravenous immunoglobulin (IVIG) treatment modulates peripheral blood Th17 and regulatory T cells in recurrent miscarriage patients: Non randomized, open-label clinical trialImmunology Letters, 2017
- Effect of Intravenous immunoglobulin on Th1 and Th2 lymphocytes and improvement of pregnancy outcome in recurrent pregnancy loss (RPL)Biomedicine & Pharmacotherapy, 2017
- The effect of intravenous immunoglobulin passive immunotherapy on unexplained recurrent spontaneous abortion: a meta-analysisReproductive BioMedicine Online, 2016
- Role of invariant natural killer T cells in lipopolysaccharide-induced pregnancy lossCellular Immunology, 2013
- Evaluation and treatment of recurrent pregnancy loss: a committee opinionFertility and Sterility, 2012
- A systematic review of intravenous immunoglobulin for treatment of unexplained recurrent miscarriageFertility and Sterility, 2011
- LUPUS ANTICOAGULANT AND RECURRENT FETAL LOSS: SUCCESSFUL TREATMENT WITH GAMMAGLOBULINThe Lancet, 1988
- The American Fertility Society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, Müllerian anomalies and intrauterine adhesionsFertility and Sterility, 1988